Phase II trial of anastrozole in women with asymptomatic müllerian cancer-Reference-Cited by-同舟云学术

Phase II trial of anastrozole in women with asymptomatic müllerian cancer

Published:2003-12 Issue:3 Volume:91 Page:596-602
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Carmen Marcela G.del,Fuller Arlan F,Matulonis Ursula,Horick Nora K,Goodman Annekathryn,Duska Linda R,Penson Richard,Campos Susana,Roche Maria,Seiden Michael V

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference21 articles.

1. Cancer statistics, 2001;Greenlee;CA Cancer J Clin,2001

2. Ovarian cancer;McNeil;J Natl Cancer Inst,1995

3. Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer;Hamerlynck;Gynecol Oncol,1985

4. A randomized, open, parallel-group trial to compare endocrine effects of oral anastrozole (Arimidex) with intramuscular formestane in postmenopausal women with advanced breast cancer;Vorobiof;Ann Oncol,1999

5. New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women;deJong;Neth J Med,1999

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics;Frontiers in Oncology;2024-07-15

2. Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature;The Oncologist;2024-05-20

3. Justification of the choice of hormone therapy for ovarian cancer;Infusion & Chemotherapy;2023-06-16

4. Insights Into the Role of Epigenetic Factors Determining the Estrogen Response in Estrogen-Positive Ovarian Cancer and Prospects of Combining Epi-Drugs With Endocrine Therapy;Frontiers in Genetics;2022-07-08

5. Aktuelles zur systemischen Rezidivtherapie des epithelialen Ovarialkarzinoms;Der Gynäkologe;2022-02-08